“Stop homosexuals, or they’ll infect us all,” screamed the headline of an opinion piece by a Baptist minister, Greg Dixon, in USA Today on June 22, 1983. Americans must “smash the homosexual movement” or it would destroy American civilization, Dixon maintained. His plea wasn’t logical, but it did reflect the fear and hatred felt by many people.
“Stop homosexuals, or they’ll infect us all,” screamed the headline of an opinion piece by a Baptist minister, Greg Dixon, in USA Today on June 22, 1983. Americans must “smash the homosexual movement” or it would destroy American civilization, Dixon maintained. His plea wasn’t logical, but it did reflect the fear and hatred felt by many people.
“Stop homosexuals, or they’ll infect us all,” screamed the headline of an opinion piece by a Baptist minister, Greg Dixon, in USA Today on June 22, 1983. Americans must “smash the homosexual movement” or it would destroy American civilization, Dixon maintained. His plea wasn’t logical, but it did reflect the fear and hatred felt by many people.
Erika, I’ve been fulminating all week about how AIDS differs from other medical conditions. Well, here’s one way in which they are the same: drug therapy is the cornerstone of treatment.
At the 1996 Vancouver conference, articles in the first issue of the conference newspaper noted that three-drug combinations reduced viral load and death of HIV-infected patients. These combinations included two types of drugs: protease inhibitors (PIs) and reverse transcriptase inhibitors. Combining the two types of drugs changed HIV from a death sentence to a chronic disease, and opened up a tantalizing possibility: “Can combination therapies eradicate HIV?” the conference newspaper asked.
Erika, I’ve been fulminating all week about how AIDS differs from other medical conditions. Well, here’s one way in which they are the same: drug therapy is the cornerstone of treatment.
At the 1996 Vancouver conference, articles in the first issue of the conference newspaper noted that three-drug combinations reduced viral load and death of HIV-infected patients. These combinations included two types of drugs: protease inhibitors (PIs) and reverse transcriptase inhibitors. Combining the two types of drugs changed HIV from a death sentence to a chronic disease, and opened up a tantalizing possibility: “Can combination therapies eradicate HIV?” the conference newspaper asked.
Erika, I’ve been fulminating all week about how AIDS differs from other medical conditions. Well, here’s one way in which they are the same: drug therapy is the cornerstone of treatment.
At the 1996 Vancouver conference, articles in the first issue of the conference newspaper noted that three-drug combinations reduced viral load and death of HIV-infected patients. These combinations included two types of drugs: protease inhibitors (PIs) and reverse transcriptase inhibitors. Combining the two types of drugs changed HIV from a death sentence to a chronic disease, and opened up a tantalizing possibility: “Can combination therapies eradicate HIV?” the conference newspaper asked.
When I covered my last AIDS conference, in Geneva in 1998, already most of the cases of HIV infection around the world were in Africa and it was clear that AIDS would devastate that continent. Also unanimous, in my perception, was a sense of helplessness about doing anything to stop that ongoing disaster.
That has all changed. This week I covered sessions about provision of antiretroviral therapy (ART) to adults and children in many African countries as well as programs to prevent mother-to-child transmission. One million people are now in treatment in Africa.
When I covered my last AIDS conference, in Geneva in 1998, already most of the cases of HIV infection around the world were in Africa and it was clear that AIDS would devastate that continent. Also unanimous, in my perception, was a sense of helplessness about doing anything to stop that ongoing disaster.
That has all changed. This week I covered sessions about provision of antiretroviral therapy (ART) to adults and children in many African countries as well as programs to prevent mother-to-child transmission. One million people are now in treatment in Africa.
When I covered my last AIDS conference, in Geneva in 1998, already most of the cases of HIV infection around the world were in Africa and it was clear that AIDS would devastate that continent. Also unanimous, in my perception, was a sense of helplessness about doing anything to stop that ongoing disaster.
That has all changed. This week I covered sessions about provision of antiretroviral therapy (ART) to adults and children in many African countries as well as programs to prevent mother-to-child transmission. One million people are now in treatment in Africa.
Erika, you are so inefficient. You had to interview two people to get pro and con views on the likelihood of an HIV vaccine. I got both sides from one person, Dr. Peggy Johnston, Director of the Vaccine and Prevention Research Program at NIAID. I asked her whether it was possible that we might never have a vaccine. “Yes, that’s possible,” she said. But she was also optimistic that the vaccine campaign would succeed.